October 9, 2015
Roche buys Adheron
A research-based healthcare company, Roche, has bought Adheron Therapeutics
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
October 9, 2015
FDA Accepts Allergan’s Supplemental New Drug Application (sNDA) for DALVANCE
Allergan plc has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Allergan’s supplemental New Drug Application (sNDA), for MRSA.
October 8, 2015
New NIH breast cancer research focuses on prevention
National Institutes of Health (NIH) has launched a new phase of the Breast Cancer and the Environment Research Program (BCERP), focused on prevention.
October 8, 2015
US FDA announces updated drug shortages list
U.S. Food & Drug Administration (FDA) has updated information on Drug Shortages.
October 7, 2015
Federal judge issues permanent injunction against South Dakota’s 2035 Inc
A federal judge in the U.S. District Court for the District of South Dakota yesterday granted the U.S. Food and…
October 7, 2015
Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study
Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, have announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.
October 6, 2015
VIDEO – Take a look at the U.S. government’s response in addressing Ebola in the United States.
Watch a video and take a look at the U.S. government’s response in addressing Ebola in the United States.
October 6, 2015
J&J Announces Completion of Cordis Divestiture to Cardinal Health
Johnson & Johnson has announced the completion of the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion, subject to customary adjustments.
October 6, 2015
AmerisourceBergen to Acquire PharMEDium Healthcare Holdings, Inc.
AmerisourceBergen has announced that it has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals in the United States, from Clayton, Dubilier & Rice for $2.575 billion in cash, subject to certain adjustments and on a cash-free, debt-free basis.